- Home
The Cardiometabolic Health Congress invites you to submit scientific poster abstracts to be presented at the 20th Annual meeting held in Boston on October 23-25, 2025.
Multidisciplinary clinicians from across the country will gather to discuss the most up-to-date developments in cardiometabolic health, including dyslipidemia, heart failure, hypertension, type 2 diabetes, weight management, and chronic kidney disease.
To enrich the attendee experience, we will offer scientific poster sessions to share the latest information from current research and clinical findings. Abstracts should address evidence-based practices and state of art clinical research that are relevant to frontline practitioners who treat patients with cardiometabolic disease.
Submit your abstract now and stay tuned for more information about which projects will be selected for publication in early 2026.
All individuals who require a visa to enter the United States are urged to immediately obtain necessary papers to attend the meeting upon submission of the abstract. A letter inviting any individual who wishes to attend may be obtained by emailing info@cardiometabolichealth.org. This letter does not imply any financial support by CMHC.
Deadlines
The abstract submission date is: September 15, 2025
Notification of abstract status is: September 30, 2025
Abstract Submission
Application Form (Required for Industry only)
All posters from industry are required to complete an application form which can be
downloaded here and emailed to Allie.Cole@informa.com. Please do NOT submit your abstract until your application has been processed and you have been notified to move forward.
Submission Details
- Completion of all submission form questions and abstract components is required.
- Abstracts may be of original research or encore (repeat) presentations of abstracts, i.e., CMHC will accept abstracts that have already been presented at other medical conferences.
- Author requirements:
- Author lists and affiliations
- List names of all authors, in order in which you wish them to appear in printed text.
- No more than 10 authors should be listed.
- List corresponding author and email address.
- A fully structured abstract should be 1,100 words or less. Author lists, correspondence information, disclosures, and acknowledgements are not part of this word limit:
- Background: 200 words
- Purpose: 150 words
- Methods: 200 words
- Results: 350 words
- Conclusions/Implications for future research and/or clinical care: 200 words
- Do not use tables, charts, or graphs in your abstract submission (they can be included in the printed poster).
- There is no limit to the number of abstracts one author may submit for consideration.
- The first author is responsible for communicating all of these policies to all involved parties.
- Completion of required copyright agreement.
- List disclosures (financial and/or in-kind support). If none, state “Nothing to disclose by any author(s).”
- List acknowledgements.
- Encore presentations: If you have previously presented your work/data as an abstract at another conference, then please list this under your Acknowledgements section.
- AI use: If an AI tool is used during the drafting process of the abstract, the author should disclose their use of generative AI by including it in the Acknowledgements section with the following:
- The statement: This abstract was initially drafted using an AI tool. The authors have reviewed, revised, and finalized the content to ensure accuracy, originality, and alignment with the intended research objectives.
- The full name of the tool used (with the version number), how it was used, and the reason for its use.
Meeting Registration Details Submission of an abstract does not automatically register you for the conference. All accepted abstracts must have a registered presenter at the 2025 meeting.
Non-Industry Registration
- Non-Students/Non-Industry: a $200 off discount code will be provided to those with accepted abstracts.
- Students only: students with an accepted abstract will be sent a complimentary registration code (ID required)
Industry Registration All accepted abstracts from industry must have a registered presenter at the 2025 meeting. Please be sure to register as "Industry" for meeting 
here.
Disclosures
CMHC requires faculty and poster authors/presenters who have an interest in selling a technology, program, product, and/or service to healthcare professionals to disclose this information in order to be considered for and/or present at any CMHC educational session.
Publication
If your abstract is accepted, you will be notified on or by September 30, 2025, and the abstract will be posted online before the meeting. Only accepted abstracts will be posted online. Abstracts will be published in an open access supplement to the peer-reviewed journal Postgraduate Medicine in January*. Abstracts will only be published with the journal if there is a registered presenter at the live meeting.
*estimated timeframe only and subject to change
Poster and Presentation Guidelines
Please bring a
physical copy of your poster to the live meeting for presentation. Below are the poster specifications and guidelines.
Print Specifications
- Posters should be:
- Printed on matte paper in a horizontal orientation, and mounted on white foamboard:
- Size: 24″ high x 36” wide.
- CMHC will provide a table and table easel to hold your mounted foam board poster.
- Print Your Poster at the Meeting: The Boston Park Plaza has a FedEx office onsite to order and pick up your poster. We suggest sending the order in a week before the meeting at latest.
- FedEx Information:
FedEx print dates and times above may change, please be sure to check the direct FedEx store website for the latest information by clicking here.
Guidelines
- While first authors typically attend the conference in person, CMHC allows other listed authors to attend in his/her place. Additional authors who are attending the conference will also need to be a registered attendee.
- Authors/presenters should bring their posters with them to the conference. Please do not send posters to the CMHC offices or in care of CMHC.
- Your poster may include figures, graphs, tables, and charts.
- No trade names should be used for drugs, devices, or instrumentation. Any medications or substances referred to in the materials must be identified by their scientific names only.
- Recording by any means (photographing, audiotaping, videotaping) of any presentation/session is prohibited, except by a CMHC authorized agent or by first author(s) who wish to photograph their own poster presentation. Violators risk confiscation of their equipment and/or dismissal from CMHC.
- QR codes with a maximum size of 1”x1” are permitted in the lower corner of posters. Scanning of a QR code only by participants using smart phones or other mobile devices is permissible.
- Interactive content/features on printed posters that can be viewed using smartphones or iPADs is allowed (for example, additional graphs, animations, videos related to the printed poster content).
- Presenters may use an iPad or tablet to facilitate their presentation, but it cannot be used in lieu of a printed poster. Tablets may also be available for viewers to see the interactive content during the poster presentation time.
- Supplementary information on how to download relevant QR codes and access interactive content may be included on the poster, i.e., within the text of the poster or printed on the bottom.
- List acknowledgements.
- Encore presentations: If you have previously presented your work/data as an abstract at another conference, then please list this under your Acknowledgements section.
- AI use: If an AI tool is used during the drafting process of the abstract, the author should disclose their use of generative AI by including it in the Acknowledgements section with the following:
- The statement: This abstract was initially drafted using an AI tool. The authors have reviewed, revised, and finalized the content to ensure accuracy, originality, and alignment with the intended research objectives.
- The full name of the tool used (with the version number), how it was used, and the reason for its use.
- For all abstracts involving human or animal studies, please ensure to state the approval by the relevant ethics committees.
- Poster presenters have the option to submit a short audio file plus a PDF version of the accepted poster. These two files will be added to the CMHC website after the conference.
- If an author wants to change or withdraw their abstract, they must contact our staff by October 3, 2025. CMHC cannot guarantee that requests submitted after this date will be accommodated. Send requests via email to info@cardiometabolichealth.org
Late-Breaking Abstracts
The CMHC late-breaking abstracts policy allows for the submission of late-breaking abstracts only for randomized phase II and phase III trials for which no preliminary data are available at the time of the abstract submission deadline (September 15, 2025), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before October 3, 2024 (deadline for the final, updated late-breaking abstract). During abstract submission, you will be required to provide the date of planned analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline. Late-breaking abstracts must follow the same abstract guidelines listed on this page.
Submission Portal
Reminder for Industry Posters: All posters from industry are required to complete an application form which can be
downloaded here and emailed to Allie.Cole@informa.com. Please do NOT enter the submission portal until your application has been processed and you have been notified to move forward. No abstracts will be accepted until this application process is complete.
